Login
Home
Charts
Search
Watchlist
Products

Supriya Lifescience Ltd

SUPRIYA·NSE
₹982.00+4.57%Wed, 23 Sept '26 12:43
Industry:Pharma - API & CRAMS
Indices:

Supriya Lifescience Ltd

SUPRIYA
NSE
₹982.00
+4.57%
|Wed, 23 Sept '26 12:43
SOICxStockScans Reports
Industry
Pharma - API & CRAMS
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹7,902Cr
Close
Close Price
₹981.85
Industry
Industry
Pharma - API & CRAMS
PE
Price To Earnings
39.83
PS
Price To Sales
9.06
Revenue
Revenue
₹873Cr
Rev Gr TTM
Revenue Growth TTM
28.14%
PAT Gr TTM
PAT Growth TTM
11.39%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
140140158161166186184145200206277190
Growth YoY
Revenue Growth YoY%
24.933.211.221.718.632.516.4-9.720.311.250.230.8
Expenses
ExpensesCr
108991039810112011793127134179142
Operating Profit
Operating ProfitCr
324156636566685273729847
OPM
OPM%
22.729.635.138.939.035.536.735.636.434.935.325.0
Other Income
Other IncomeCr
232232333233
Interest Expense
Interest ExpenseCr
001001010000
Depreciation
DepreciationCr
444555667799
PBT
PBTCr
304053606263644768679241
Tax
TaxCr
61016151616141318171817
PAT
PATCr
243037454647503550507424
Growth YoY
PAT Growth YoY%
41.6212.9-3.456.693.357.036.4-22.19.36.247.3-30.9
NPM
NPM%
17.021.323.427.827.825.227.424.025.224.126.812.7
EPS
EPS₹
3.03.74.65.55.75.86.34.36.36.29.23.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
140140158161166186184145200206277190
Growth YoY
Revenue Growth YoY%
24.933.211.221.718.632.516.4-9.720.311.250.230.8
Expenses
ExpensesCr
108991039810112011793127134179142
Operating Profit
Operating ProfitCr
324156636566685273729847
OPM
OPM%
22.729.635.138.939.035.536.735.636.434.935.325.0
Other Income
Other IncomeCr
232232333233
Interest Expense
Interest ExpenseCr
001001010000
Depreciation
DepreciationCr
444555667799
PBT
PBTCr
304053606263644768679241
Tax
TaxCr
61016151616141318171817
PAT
PATCr
243037454647503550507424
Growth YoY
PAT Growth YoY%
41.6212.9-3.456.693.357.036.4-22.19.36.247.3-30.9
NPM
NPM%
17.021.323.427.827.825.227.424.025.224.126.812.7
EPS
EPS₹
3.03.74.65.55.75.86.34.36.36.29.23.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
171184213278312391530461570696828873
Growth
Revenue Growth%
23.87.516.030.512.225.535.5-13.023.722.118.928.1
Expenses
ExpensesCr
150166191213213218316332397436534583
Operating Profit
Operating ProfitCr
2017226598173214129173261294290
OPM
OPM%
11.99.310.323.331.644.340.428.030.337.435.533.2
Other Income
Other IncomeCr
27981158911101111
Interest Expense
Interest ExpenseCr
1012111074432222
Depreciation
DepreciationCr
455567101216202831
PBT
PBTCr
88145796167207123166248275268
Tax
TaxCr
226182344553447616670
PAT
PATCr
669397312415290119188209198
Growth
PAT Growth%
-30.6-0.654.2351.786.068.522.8-40.832.657.811.311.4
NPM
NPM%
3.33.14.114.223.531.628.619.520.927.025.322.7
EPS
EPS₹
3.93.91.25.410.016.918.911.214.823.426.024.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
171184213278312391530461570696828873
Growth
Revenue Growth%
23.87.516.030.512.225.535.5-13.023.722.118.928.1
Expenses
ExpensesCr
150166191213213218316332397436534583
Operating Profit
Operating ProfitCr
2017226598173214129173261294290
OPM
OPM%
11.99.310.323.331.644.340.428.030.337.435.533.2
Other Income
Other IncomeCr
27981158911101111
Interest Expense
Interest ExpenseCr
1012111074432222
Depreciation
DepreciationCr
455567101216202831
PBT
PBTCr
88145796167207123166248275268
Tax
TaxCr
226182344553447616670
PAT
PATCr
669397312415290119188209198
Growth
PAT Growth%
-30.6-0.654.2351.786.068.522.8-40.832.657.811.311.4
NPM
NPM%
3.33.14.114.223.531.628.619.520.927.025.322.7
EPS
EPS₹
3.93.91.25.410.016.918.911.214.823.426.024.6

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1515151515151616161616
Reserves
ReservesCr
263140791342546006837999811,182
Current Liabilities
Current LiabilitiesCr
150144146135155146100967787121
Non Current Liabilities
Non Current LiabilitiesCr
3951452432311925293338
Total Liabilities
Total LiabilitiesCr
2312412452533364457358209211,1171,357
Current Assets
Current AssetsCr
129115120133196265498465398442532
Non Current Assets
Non Current AssetsCr
102126126120141180237355523675825
Total Assets
Total AssetsCr
2312412452533364457358209211,1171,357
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1515151515151616161616
Reserves
ReservesCr
263140791342546006837999811,182
Current Liabilities
Current LiabilitiesCr
150144146135155146100967787121
Non Current Liabilities
Non Current LiabilitiesCr
3951452432311925293338
Total Liabilities
Total LiabilitiesCr
2312412452533364457358209211,1171,357
Current Assets
Current AssetsCr
129115120133196265498465398442532
Non Current Assets
Non Current AssetsCr
102126126120141180237355523675825
Total Assets
Total AssetsCr
2312412452533364457358209211,1171,357

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
14272849117764964113165186
Investing Cash Flow
Investing Cash FlowCr
-33-26-55-25-47-60-124-174-152-176
Financing Cash Flow
Financing Cash FlowCr
21-2-20-50-29-15150-10-22-8-10
Net Cash Flow
Net Cash FlowCr
2-2346215139-70-8340
Free Cash Flow
Free Cash FlowCr
-51823549229-11-44-32234
CFO To PAT
CFO To PAT%
237.2471.5318.0124.0159.161.432.170.895.187.688.8
CFO To EBITDA
CFO To EBITDA%
66.4155.9126.475.5118.643.822.849.465.563.163.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
14272849117764964113165186
Investing Cash Flow
Investing Cash FlowCr
-33-26-55-25-47-60-124-174-152-176
Financing Cash Flow
Financing Cash FlowCr
21-2-20-50-29-15150-10-22-8-10
Net Cash Flow
Net Cash FlowCr
2-2346215139-70-8340
Free Cash Flow
Free Cash FlowCr
-51823549229-11-44-32234
CFO To PAT
CFO To PAT%
237.2471.5318.0124.0159.161.432.170.895.187.688.8
CFO To EBITDA
CFO To EBITDA%
66.4155.9126.475.5118.643.822.849.465.563.163.2

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,9671,5352,6705,9044,5487,902
Price To Earnings
Price To Earnings
26.117.122.431.421.839.8
Price To Sales
Price To Sales
7.53.34.78.55.59.1
Price To Book
Price To Book
6.42.23.35.93.86.6
EV To EBITDA
EV To EBITDA
17.610.915.022.415.226.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.826.426.337.547.861.556.950.051.258.956.056.0
OPM
OPM%
11.99.310.323.331.644.340.428.030.337.435.533.2
NPM
NPM%
3.33.14.114.223.531.628.619.520.927.025.322.7
ROCE
ROCE%
10.710.714.337.645.250.332.917.520.425.023.023.0
ROE
ROE%
14.012.316.042.049.246.024.712.814.618.917.517.5
ROA
ROA%
2.52.43.615.621.827.720.710.912.916.815.415.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,9671,5352,6705,9044,5487,902
Price To Earnings
Price To Earnings
26.117.122.431.421.839.8
Price To Sales
Price To Sales
7.53.34.78.55.59.1
Price To Book
Price To Book
6.42.23.35.93.86.6
EV To EBITDA
EV To EBITDA
17.610.915.022.415.226.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.826.426.337.547.861.556.950.051.258.956.056.0
OPM
OPM%
11.99.310.323.331.644.340.428.030.337.435.533.2
NPM
NPM%
3.33.14.114.223.531.628.619.520.927.025.322.7
ROCE
ROCE%
10.710.714.337.645.250.332.917.520.425.023.023.0
ROE
ROE%
14.012.316.042.049.246.024.712.814.618.917.517.5
ROA
ROA%
2.52.43.615.621.827.720.710.912.916.815.415.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Supriya Lifescience Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/119d72ck9ln5eyj5gfljzs4r.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/l10uxezp6vaixai52p25fkbo.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/7dsxnqyenlx8ebhk3wq5s7dk.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/z1hv16oy4d86ilerh6279s2x.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/2rrplin8xkr8a31kyf99rz5s.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/fmotskrq8qrrl3agesm1b6rq.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/5g7itz5n3otr8vunxvmgst1o.pdf
  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/5hbcpv4xn6ylf6xfjxofiuho.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/nxhw5qlyze5g2hlcul27465g.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/dim2bhzosl4i35d6y9zuamnp.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/wjg83wuov0wifbipmfkwk6ro.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/ombklfjuw3y53wb7xcs916hi.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/3pefh2u8aimku3y1ympi84g3.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/xhu56yjoinicfx70xo6drpue.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/n9npw0dz8s6wgq5wyim0gb6w.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/ekbim1pcuhqzfl7iekzbn85c.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/ibmd23gv2s72ahokvx39lm8m.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/pdefpd4czs1vcwbgwhz1w8jk.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/te9n4l7h574m6fucl8e1tsxm.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/jfr7vuqi7e3xdo4jnp0m6mqm.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/7uaz67zyb7jgrsvaop4wdyag.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/cj4uateop6euzdztnm5osu8o.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/s841eqp5ewhkjg0x8wxug7ba.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/5h9546wyi8ldj9ggfdn4h19h.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/ej0vum615m681ri9vil7yh24.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/lare6xihi46oiksm1pthjytt.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/vm34qlrqb20wu0c05g4hzymg.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/v34y92tjy6fjh8zwibd1xlfh.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/vppurgu6f854jwxkktvemoce.pdf

Concall Transcript Summaries — Supriya Lifescience Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ASUPRIYA/transcript-notes/202606/119d72ck9ln5eyj5gfljzs4r.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ASUPRIYA/transcript-notes/202603/l10uxezp6vaixai52p25fkbo.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ASUPRIYA/transcript-notes/202512/7dsxnqyenlx8ebhk3wq5s7dk.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ASUPRIYA/transcript-notes/202509/z1hv16oy4d86ilerh6279s2x.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ASUPRIYA/transcript-notes/202412/2rrplin8xkr8a31kyf99rz5s.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ASUPRIYA/transcript-notes/202409/fmotskrq8qrrl3agesm1b6rq.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3ASUPRIYA/transcript-notes/202406/5g7itz5n3otr8vunxvmgst1o.pdf
  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3ASUPRIYA/transcript-notes/202403/5hbcpv4xn6ylf6xfjxofiuho.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies